Healthcare Wire Texas: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Wire Texas.

February 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28

March 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28	29
30	31

April 2026

Mo	Tu	We	Th	Fr	Sa	Su
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30

Press releases published on April 10, 2026

Apr. 10, 2026

Margie Barilla Foundation Donates Prom Dresses to Support Local Youth in Collin County

EIN Presswire

Apr. 10, 2026

New Dementia Care Models Released by Village Green Community

EIN Presswire

Apr. 10, 2026

AIOMEGA® to Publish and Present Six Studies at AADSM, AASM, SSS on AIO Breathe® Adult and Pediatric Airway Therapy

EIN Presswire

Apr. 10, 2026

Ann Crile Esselstyn, 90, Sets Guinness World Record, Illustrating Plant Strong’s Vision for Lifelong Vitality

EIN Presswire

Apr. 10, 2026

Gentle Patches Claims Evaluated: 2026 Consumer Interest Rises Around Transdermal Wellness Patch Ingredients, Product Lineup, and Policy Transparency

GlobeNewswire

Apr. 10, 2026

Consilium Staffing Launches Emergency Medicine Division

EIN Presswire

Apr. 10, 2026

U.S. Marine Veteran Releases ‘Faith Then Freedom’ Book – A Powerful Story of Addiction, Redemption, and Recovery

EIN Presswire

Apr. 10, 2026

Glo & Spa-rkle Aesthetics and Medical Spa Unveils New State-of-the-Art Location in Lubbock, Texas

GlobeNewswire

Apr. 10, 2026

IVY Rx Claims Evaluated: 2026 Compounded GLP-1 Telehealth Program Details, Monthly Pricing Structure, Clinician Access Model, and Patient Eligibility Information

GlobeNewswire

Apr. 10, 2026

ReadyRx NAD+ Rx Claims Evaluated: 2026 Update Highlights Changes in Prescription NAD+ Nasal Spray and Injection Access, Pricing, and Telehealth Eligibility

GlobeNewswire

Apr. 10, 2026

Replimune Receives Complete Response Letter from the FDA for RP1 Biologics License Application for the Treatment of Advanced Melanoma

GlobeNewswire

Apr. 10, 2026

Pelthos Therapeutics Announces CFO Transition

GlobeNewswire

Apr. 10, 2026

Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

Apr. 10, 2026

Mesoblast Receives IND Clearance From FDA to Directly Proceed to Registrational Trial for Approval of Ryoncil® in Duchenne Muscular Dystrophy - CORRECTION

GlobeNewswire

Apr. 10, 2026

Spyre Therapeutics to Host Conference Call to Report SPY001 Part A Induction Topline Results from SKYLINE Trial in Moderate-to-Severe Ulcerative Colitis Patients on April 13, 2026

GlobeNewswire

Apr. 10, 2026

Korro Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

Apr. 10, 2026

Allogene Therapeutics to Announce Interim Futility Analysis Data from its Pivotal Phase 2 ALPHA3 Trial with Cemacabtagene Ansegedleucel (Cema-Cel) in First-Line Consolidation LBCL on Monday, April 13, 2026

GlobeNewswire

Apr. 10, 2026

IRADIMED CORPORATION to Participate at the 25th Annual Needham Virtual Healthcare Conference

GlobeNewswire

Apr. 10, 2026

Best Medical Alert Systems 2026: Bay Alarm Medical Awarded Best Medical Alert System

GlobeNewswire

Apr. 10, 2026

Suja Life Announces Filing of Registration Statement for Proposed Initial Public Offering

GlobeNewswire